Cardiothoracic Imaging: Diagnostics and Modern Techniques—2nd Edition

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".

Deadline for manuscript submissions: 31 October 2024 | Viewed by 2392

Special Issue Editors


E-Mail Website
Guest Editor
2nd Department of Radiology, Faculty of Health Sciences with the Institute of Maritime and Tropical Medicine, Medical University of Gdansk, 80-214 Gdansk, Poland
Interests: neuroradiology (CT and MR diagnosis of CNS diseases—hypertension and changes in the brain; brain and spinal cord tumors); chronic liver diseases; liver tumors; pancreatic tumors; inflammatory bowel disease; inflammatory diseases of the digestive system; oncological imaging (e.g., oncological uroradiology); spiral computed tomography (CT) and Magnetic Resonance Imaging (MRI); diagnosis of parotid gland tumors; lung-cancer diagnosis; osteoarticular system; pediatric radiology; imaging of the heart and large vessels; use of mathematical models and methods of computer image processing in medicine; radiological–pathological correlations; virtual autopsy
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
2nd Department of Radiology, Medical University of Gdansk, Gdansk, Poland
Interests: clinical significance of modern imaging methods (CT, MRI) in selected diffuse pancreatic diseases; clinical implications of ectopic adipose tissue accumulation in individual organs; tumors and inflammation of the pancreas and intestines; perfusion CT in patients with insulin-dependent diabetes; imaging of the heart and large vessels; cardiological diagnostics using CT and MRI; oncological diagnostics; diagnosis of diseases of the genitourinary system; lung cancer

E-Mail Website
Guest Editor
2nd Department of Radiology, Medical University of Gdansk, Gdansk, Poland
Interests: oncology; chest imaging; lung cancer screening; drug development; ageing; neurodegenerative diseases; AI in medicine; radiomics; robotics

Special Issue Information

Dear Colleagues,

During the last decade, imaging techniques have become increasingly complex, providing greater opportunities for disease understanding and enabling appropriate diagnoses to be made quickly and with greater precision. Cardiothoracic imaging using computed tomography (CT), magnetic resonance imaging (MRI), echocardiography, and positron emission tomography (PET) plays a key role in the diagnosis of heart, great vessels, and lung diseases.

The therapeutic decision in patients with cardiovascular and pulmonary problems is often made in multidisciplinary teams, in which radiological evaluation plays an integral part. This Special Issue will focus on the role of a radiologist in diagnostic and therapeutic teams, and the importance of imaging studies in a comprehensive approach to treatment and follow-up. Current guidelines for the use of imaging studies in specific clinical situations and disease entities will be discussed, and the benefits of using new study protocols and sequences will be demonstrated, with examples provided. We will discuss both ischemic and non-ischemic heart disease and advances in cardiac imaging.

Regarding chest imaging, we will focus on lung-cancer screening (LCS) using low-dose CT and the directions of its development, such as the implementation of artificial intelligence (AI), including the use of machine learning (ML).

The main topics of the Special Issue include:

  1. How to accurately visualize cardiac lesions.
  2. How to improve the LCS program.
  3. How to cooperate in joint multidisciplinary teams.

Prof. Dr. Edyta Szurowska
Dr. Joanna Pieńkowska
Dr. Joanna Bidzińska
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cardiac imaging
  • chest imaging
  • diagnostics
  • MRI
  • CT
  • AI
  • lung cancer screening
  • heart disease
  • imaging techniques
  • COVID-19

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

14 pages, 5326 KiB  
Article
Clinical Role of Upfront F-18 FDG PET/CT in Determining Biopsy Sites for Lung Cancer Diagnosis
by Byunggeon Park, Jae-Kwang Lim, Kyung Min Shin, Jihoon Hong, Jung Guen Cha, Seung Hyun Cho, Seo Young Park, Hun Kyu Ryeom, See Hyung Kim, An Na Seo, Seung-Ick Cha, Jaehee Lee, Hoseok Lee and Jongmin Park
Diagnostics 2024, 14(2), 153; https://doi.org/10.3390/diagnostics14020153 - 09 Jan 2024
Viewed by 780
Abstract
Purpose: This study aimed to investigate the impact of FDG PET/CT timing for biopsy site selection in patients with stage IV lung cancer regarding complications and diagnostic yield. Methods: This retrospective analysis was performed on 1297 patients (924 men and 373 women with [...] Read more.
Purpose: This study aimed to investigate the impact of FDG PET/CT timing for biopsy site selection in patients with stage IV lung cancer regarding complications and diagnostic yield. Methods: This retrospective analysis was performed on 1297 patients (924 men and 373 women with a mean age of 71.4 ± 10.2 years) who underwent percutaneous needle biopsy (PNB) for stage IV lung cancer diagnosis in two hospitals. Data collected included the patient’s characteristics, order date of the biopsy and PET/CT exams, biopsy target site (lung or non-lung), guidance modality, complications, sample adequacy, and diagnostic success. Based on the order date of the PNB and PET/CT exams, patients were categorized into upfront and delayed PET/CT groups. Results: PNB for non-lung targets resulted in significantly lower rates of minor (8.1% vs. 16.2%), major (0.2% vs. 3.4%), and overall complications (8.3% vs. 19.6%) compared to PNB for lung targets (p < 0.001 for all types of complications). Compared to the delayed PET/CT group, the upfront PET/CT group exhibited a lower probability of lung target selection of PNB (53.9% vs. 67.1%, p < 0.001), including a reduced incidence of major complications (1.0% vs. 2.9%, p = 0.031). Moreover, there was no significant difference in the occurrence of minor and total complications between the two groups. Upfront PET/CT and delayed PET/CT groups showed no significant difference regarding sample adequacy and diagnostic success. Conclusions: Upfront PET/CT may have an impact on the selection of the biopsy site for patients with advanced lung cancer, which could result in a lower rate of major complications with no change in the diagnostic yield. Upfront PET/CT demonstrates potential clinical implications for enhancing the safety of lung cancer diagnosis in clinical practice. Full article
Show Figures

Figure 1

12 pages, 2457 KiB  
Article
An Intra-Individual Comparison of Low-keV Photon-Counting CT versus Energy-Integrating-Detector CT Angiography of the Aorta
by Jan-Lucca Hennes, Henner Huflage, Jan-Peter Grunz, Viktor Hartung, Anne Marie Augustin, Theresa Sophie Patzer, Pauline Pannenbecker, Bernhard Petritsch, Thorsten Alexander Bley and Philipp Gruschwitz
Diagnostics 2023, 13(24), 3645; https://doi.org/10.3390/diagnostics13243645 - 12 Dec 2023
Viewed by 575
Abstract
This retrospective study aims to provide an intra-individual comparison of aortic CT angiographies (CTAs) using first-generation photon-counting-detector CT (PCD-CT) and third-generation energy-integrating-detector CT (EID-CT). High-pitch CTAs were performed with both scanners and equal contrast-agent protocols. EID-CT employed automatic tube voltage selection (90/100 kVp) [...] Read more.
This retrospective study aims to provide an intra-individual comparison of aortic CT angiographies (CTAs) using first-generation photon-counting-detector CT (PCD-CT) and third-generation energy-integrating-detector CT (EID-CT). High-pitch CTAs were performed with both scanners and equal contrast-agent protocols. EID-CT employed automatic tube voltage selection (90/100 kVp) with reference tube current of 434/350 mAs, whereas multi-energy PCD-CT scans were generated with fixed tube voltage (120 kVp), image quality level of 64, and reconstructed as 55 keV monoenergetic images. For image quality assessment, contrast-to-noise ratios (CNRs) were calculated, and subjective evaluation (overall quality, luminal contrast, vessel sharpness, blooming, and beam hardening) was performed independently by three radiologists. Fifty-seven patients (12 women, 45 men) were included with a median interval between examinations of 12.7 months (interquartile range 11.1 months). Using manufacturer-recommended scan protocols resulted in a substantially lower radiation dose in PCD-CT (size-specific dose estimate: 4.88 ± 0.48 versus 6.28 ± 0.50 mGy, p < 0.001), while CNR was approximately 50% higher (41.11 ± 8.68 versus 27.05 ± 6.73, p < 0.001). Overall image quality and luminal contrast were deemed superior in PCD-CT (p < 0.001). Notably, EID-CT allowed for comparable vessel sharpness (p = 0.439) and less pronounced blooming and beam hardening (p < 0.001). Inter-rater agreement was good to excellent (0.58–0.87). Concluding, aortic PCD-CTAs facilitate increased image quality with significantly lower radiation dose compared to EID-CTAs. Full article
Show Figures

Figure 1

Other

Jump to: Research

5 pages, 587 KiB  
Interesting Images
Coexistence of Left Atrial Tumor and Lung Cancer—The Key Role of an Individualized Approach
by Maja Hawryszko, Grzegorz Sławiński, Hanna Jankowska, Karolina Dorniak, Anna Kochańska, Ludmiła Daniłowicz-Szymanowicz and Ewa Lewicka
Diagnostics 2024, 14(2), 133; https://doi.org/10.3390/diagnostics14020133 - 06 Jan 2024
Viewed by 754
Abstract
During the diagnostic work-up in oncology, it is exceedingly rare to assume a concomitant presence of two cancers, a benign one and a malignant one, in a single patient. A 61-year-old man was admitted to the cardiology department for cardiac evaluation prior to [...] Read more.
During the diagnostic work-up in oncology, it is exceedingly rare to assume a concomitant presence of two cancers, a benign one and a malignant one, in a single patient. A 61-year-old man was admitted to the cardiology department for cardiac evaluation prior to planned radical treatment of non-small cell (NSCLC) left lung cancer (cT3N1M0). Echocardiography revealed a prominent, unpedunculated structure, measuring 17 × 14 mm, located in the left atrium (LA) near the fossa ovalis. The tumor was confirmed via cardiac magnetic resonance (CMR) imaging, which showed the radiological features of an atrial myxoma. The patient consulted with the Cardiac Surgery Department and was deemed ineligible for surgical treatment of a lesion with mucinous features; thus, no definitive histopathologic confirmation of the tumor present was possible. He was then successfully treated with radical radiochemotherapy and immunotherapy. During the 2-year follow-up, regular echocardiography and CMR were performed, which documented a stable LA tumor size. Full article
Show Figures

Figure 1

Back to TopTop